Trail Ridge Investment Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.6M Buy
7,561
+221
+3% +$47.6K 0.69% 37
2025
Q4
$1.51M Buy
7,340
+524
+8% +$98.6K 0.65% 37
2025
Q3
$1.07M Buy
6,816
+119
+2% +$18.4K 0.48% 46
2025
Q2
$1.04M Buy
6,697
+61
+0.9% +$9.05K 0.5% 45
2025
Q1
$914K Buy
6,636
+154
+2% +$19.6K 0.47% 47
2024
Q4
$767K Sell
6,482
-4
-0.1% -$467 0.36% 55
2024
Q3
$726K Sell
6,486
-124
-2% -$13K 0.35% 61
2024
Q2
$650K Buy
6,610
+393
+6% +$40K 0.34% 62
2024
Q1
$696K Buy
6,217
+720
+13% +$77.7K 0.39% 58
2023
Q4
$554K Buy
5,497
+83
+2% +$8.23K 0.34% 61
2023
Q3
$470K Buy
5,414
+629
+13% +$56.9K 0.32% 65
2023
Q2
$453K Buy
4,785
+834
+21% +$70.4K 0.28% 72
2023
Q1
$298K Buy
+3,951
New +$298K 0.19% 98

Other funds holding CAH

Trail Ridge Investment Advisors's CAH Position: Q1 2026 in Review

Trail Ridge Investment Advisors increased its Cardinal Health (CAH) stake by 3% in Q1 2026, buying an estimated $47.6K and bringing the position to 7,561 shares worth $1.6M. The position accounts for 0.69% of the portfolio, ranked #37.

Trail Ridge Investment Advisors first reported a position in CAH in Q1 2023 and has held it in 13 quarters since. 1,424 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Trail Ridge Investment Advisors held 7,561 shares of Cardinal Health worth $1.6M as of Q1 2026.
  • Trail Ridge Investment Advisors bought 221 Cardinal Health shares in Q1 2026, an estimated $47.6K.
  • Cardinal Health made up 0.69% of Trail Ridge Investment Advisors's portfolio in Q1 2026, its #37 holding.
  • Trail Ridge Investment Advisors first reported a position in Cardinal Health in Q1 2023 and has held it in 13 quarters since.
  • 1,424 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Trail Ridge Investment Advisors's 13F filing for Q1 2026, filed 5 May 2026.